One binder delivered as rabbit IgG.
You bring the target and we deliver the same validated binder in every antibody format your assay needs.
Everything is produced from stable, sequence-defined cell lines. The binder never changes, only the Fc adapts.
The Platform
Sequence-defined, format-flexible recombinant antibodies.
Explore the technology →Who We Are
An early-stage deeptech team at DTU Skylab building the next generation of antibodies.
Meet the team →Work With Us
Currently accepting pilot service agreements. Tell us your target and the formats you need.
Get in touch →Antibody reproducibility is broken
Batch-to-batch variability
Hybridoma and polyclonal antibodies drift between lots because their identity is defined by a living biological source, not a sequence.
Format inflexibility
Need a rabbit IgG instead of a mouse IgG? You need a different supplier, a new validation, and hope the specificity matches.
Wasted resources
A significant fraction of irreproducible results in published literature trace back to antibody variability, a solvable problem.
The Abii Platform
Abii separates the antigen-binding region (the binder) from the antibody's constant region (the Fc). The same validated binder can be rapidly reformatted into different IgG architectures without redesigning the production process.
- Sequence-defined: same construct, same antibody, every batch.
- Modular Fc: swap species, isotype or effector profile without touching the paratope.
- Proprietary expression system for coordinated heavy and light chain production.
Engineered from the binder. Adapted to your experiment.
Ready to work with Abii?
We are currently running pilot service agreements. Contact us to discuss your specific antibody needs.
Get in Touch